about
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas.Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsMendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancerVariation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databaseLow anterior resection combined with a covering stoma in the treatment of rectal cancer reduces the risk of permanent anastomotic failure.CTCF/cohesin-binding sites are frequently mutated in cancer.Pattern of rectal cancer recurrence after curative surgery.Systematic search for rare variants in Finnish early-onset colorectal cancer patients.Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.
P50
Q29417133-0133D608-EB5B-47A5-937C-203198A56480Q30252873-3634ABF2-732F-4EA9-A12F-E6C5FDF90544Q35878544-786BC08B-19A3-4697-98A4-6A5F02EA01C4Q36213561-F33368DA-331C-4A10-9C49-2F226C5FE9BBQ36824964-24D082DF-AC75-4AC3-9DEC-BC59C6F15113Q37100729-34DE32CA-C41F-4EA1-94D0-58F271B1F4CBQ37367984-AEA4F512-B724-472B-8B08-4FE53901F7D5Q38614073-3D177A03-F04C-4C61-AB32-26C8EAE9B5D2Q38691039-D44DA2F1-3979-4226-AD09-9F220575D2ABQ40216142-EFFA3720-F0AC-4AD6-A3FE-62BE156B4861Q40221041-9D1E9C3D-16E0-4227-BA13-DC660812465AQ40719336-62CBF1A6-BD52-4F8B-9DF0-5EAB2E26B57FQ40796891-5FE8A69C-D081-4403-A412-933D67A933D9Q40859240-D7E1058F-E382-4F2B-993F-10D0A40458F7Q41183550-9432B7EB-DC7E-4D7E-B0E2-7C4CC0449372Q41272894-8593BDAD-E1BE-40ED-8C5A-F7AFB62115BCQ42374502-DA9396A1-79C3-402C-92B3-2BD891539117
P50
description
onderzoeker
@nl
name
Laura Renkonen-Sinisalo
@ast
Laura Renkonen-Sinisalo
@en
Laura Renkonen-Sinisalo
@es
Laura Renkonen-Sinisalo
@nl
Laura Renkonen-Sinisalo
@sl
type
label
Laura Renkonen-Sinisalo
@ast
Laura Renkonen-Sinisalo
@en
Laura Renkonen-Sinisalo
@es
Laura Renkonen-Sinisalo
@nl
Laura Renkonen-Sinisalo
@sl
prefLabel
Laura Renkonen-Sinisalo
@ast
Laura Renkonen-Sinisalo
@en
Laura Renkonen-Sinisalo
@es
Laura Renkonen-Sinisalo
@nl
Laura Renkonen-Sinisalo
@sl